Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00018889 · ClinicalTrials.gov registry record

Phenotype/Genotype Correlations in Movement Disorders

A clinical trial of Movement Disorder, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).

Recruiting
Registry status
2,500
Enrollment target
1
Study location

NCT00018889: Recruiting study of Movement Disorder, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).

NCT00018889 is a study of Movement Disorder that is actively recruiting participants, run by National Institute of Neurological Disorders and Stroke (NINDS). The registered enrollment target is 2,500 participants, below the 4,124-participant average among 6 other Movement Disorder trials with a reported enrollment target (39% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00018889, a study of Movement Disorder, is actively recruiting participants, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).

RECRUITING
Registry status
2,500 participants
Enrollment target
1
Study location

Study Summary

The goal of this protocol is to identify families with inherited movement disorders and evaluate disease manifestations to establish an accurate clinical diagnosis by using newest technological advances and investigate the underlying molecular mechanisms. Studies of inherited movement disorders in large families with good genealogical records are especially valuable. Patients with diseases of known molecular basis will be genotyped in order to investigate phenotype/genotype correlation. Patients with disease of unknown or incomplete genetic characterization will be studied with a hope of contributing to the identification of specific disease-causing genes and genetic mechanisms responsible for a specific disorder.

Primary Outcome

Characterizations to determine their eligibility for inclusion in other NIH protocols.

Conditions Studied

Study Locations (1)

Maryland

  • National Institutes of Health Clinical Center - Bethesda

Trial Details

FieldValue
Enrollment Target 2,500 participants
Start Date 2001-10-22

What NCT00018889 shows while recruiting

NCT00018889 is an observational study that tracks outcomes without assigning an intervention. Its 2,500 participants enrollment target places it among the larger protocols in the corpus, below the 4,124-participant average among 6 other Movement Disorder trials with a reported enrollment target (39% lower).

The record links to 1 condition, with Movement Disorder appearing as the primary indexed condition, and to 0 interventions.

NCT00018889 reports a single indexed study location in Maryland.

Frequently Asked Questions

What is clinical trial NCT00018889 about?

NCT00018889 is a clinical study titled "Phenotype/Genotype Correlations in Movement Disorders". The goal of this protocol is to identify families with inherited movement disorders and evaluate disease manifestations to establish an accurate clinical diagnosis by using newest technological advances and investigate the underlying molecular mechanisms. Studies of inherited movement disorders in l...

What is the current status of trial NCT00018889?

This trial is currently recruiting. The enrollment target is 2,500 participants. The study started on 2001-10-22.

What conditions does trial NCT00018889 study?

This clinical trial studies the following conditions: Movement Disorder.

Who is sponsoring clinical trial NCT00018889?

This trial is sponsored by National Institute of Neurological Disorders and Stroke (NINDS), which has 567 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00018889 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Movement Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00001160 · 2,500 participants

    Studies on Tumors of the Thyroid

  • NCT01904188 · 2,500 participants

    Clinical Microbial Species & Antibiotic Resistance ID in ED Patients Presenting With Infection - is Rapid ID Possible & Accurate?

  • NCT02257229 · 2,500 participants

    Prospective Evaluation of Treatment for Clubfoot

  • NCT02530658 · 2,500 participants

    Next Generation Sequencing of Normal Tissues Prospectively in Pediatric Oncology Patients

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT00018889, the US trial registry maintained by the National Library of Medicine. NCT00018889 (large enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.